Status:
COMPLETED
Validation of a Contactless Vital Signs Measurement Sensor
Lead Sponsor:
Sleepiz AG
Conditions:
Sleep Apnea
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary aim of this study is to validate the performance of Sleepiz One+ for the measurement of vital physiological parameters in adult population, against a laboratory-based polysomnography. Addi...
Eligibility Criteria
Inclusion
- Age \>18years
- Ability and consent to undergo electrophysiological routine assessment
- Informed Consent as documented by signature
- Patients diagnosed or suspected to suffer from sleep apnea or any other sleep related disorder or patients suffering from chronic cardiac, respiratory or neuromuscular disorders
- Ambulatory or stationary patients of Klinik Lengg
Exclusion
- Previous enrolment into the current study,
- Enrolment of the investigator, his/her family members, employees and other dependent persons
- Cardiac pacemaker or another implanted electrical device
- Women who are pregnant
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, delirium etc. of the participant
Key Trial Info
Start Date :
September 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 12 2022
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT04676191
Start Date
September 10 2020
End Date
January 12 2022
Last Update
January 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinik Lengg AG
Zurich, Switzerland